Vitura JV Cortexa starts local manufacture of MDMA by Martin Lane April 5, 2024July 16, 2024 Vitura Health joint venture Cortexa has started batch manufacturing GMP MDMA 40mg capsules to support clinical […]
Emyria inks deal to study MDMA-assisted therapy for first responders by Martin Lane April 3, 2024July 16, 2024
Emyria S3 CBD trial ‘on hold’ as firm stresses need to focus on revenue by Steve Jones February 7, 2024February 7, 2024
Vitura JV to take delivery of first batch of psychedelic medicines by cannabiz team July 26, 2023April 30, 2024
Emyria shares take a hit as company raises another A$2.5 million by Steve Jones May 1, 2023April 30, 2024
Emyria and LGP shares soar after TGA approves limited access to MDMA and psilocybin by Steve Jones February 6, 2023April 29, 2024
Emyria posts A$7m loss but insists 2023 will be ‘momentous’ by Steve Jones August 30, 2022April 29, 2024
Emyria losses deepen as drug development takes centre stage by Steve Jones March 1, 2022April 29, 2024
TGA releases findings on MDMA and psilocybin as mental health treatments by Martin Lane October 5, 2021April 26, 2024
